Inventor
Andrew Sharpe
Inventor
Saffron Walden, GB
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes13%
C02FTreatment of water, waste water, sewage, or sludge6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers2%
C09KMaterials for miscellaneous applications, not provided for elsewhere2%
G03GElectrography2%
H01BCables2%
PatentTitleYear
10,793,559Chemical compounds202010,457,674Chemical compounds201910,214,509Amino-substituted heterocyclic derivatives as sodium channel inhibitors201910,130,619Amido thiadiazole derivatives as NADPH oxidase inhibitors20189,931,323Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use20189,505,746'Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use'20169,328,106'Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use'20168,785,628'Triazine derivatives as kinase inhibitors'20148,653,105'Quinoline derivatives as kinase inhibitors'20148,637,543'Quinoline derivatives as kinase inhibitors'20148,614,206'Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use'20138,513,284'Fused pyridine and pyrazine derivatives as kinase inhibitors'20138,399,483'Quinoxaline and quinoline derivatives as kinase inhibitors'20138,324,204'Fused thiophene derivatives as kinase inhibitors'20126,809,100'Hydroxamic acid derivatives'20046,787,536'Hydroxamic acid derivatives'20046,734,189'Hydroxamic and carboxylic acid derivatives'20046,469,020'Hydroxamic and carboxylic acid derivatives'20026,403,791'Heterocyclic compounds and their therapeutic use'20026,313,116'Benzothiazole compounds and their therapeutic use'20016,169,090'Heterocyclic compounds and their therapeutic use'20016,066,657'Benzofuran-4-carboxamides and their therapeutic use'20005,779,087'Closing tab'19984,990,263'Melamine-formaldehyde resins in the flocculation of high solids mineral slurries'19914,990,262'Preparation of high solid mineral slurries'19914,741,838'Flocculation of high solids mineral slurries'19884,647,382'Flocculation of high solids mineral slurries'19874,100,079'Polymers for acid thickening'19784,040,984'Electroconductive polysalt complexes'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1987–1991Based in Comfort, WV, US· patent location history
1998Based in Concord, NH, US· patent location history
2000–2004Patents assigned to DARWIN DISCOVERY LTD (8)· patent assignee history
2000–2004Based in Cambridge, GB· patent location history
2012–2014Patents assigned to SHARPE ANDREW (6)· patent assignee history
2012–2014Patents assigned to UCB PHARMA SA (6)· patent assignee history
2012–2014Patents assigned to HAUGHAN ALAN FINDLAY (5)· patent assignee history
2012Based in Slough, GB· patent location history
2013–2014Patents assigned to ALLEN DANIEL REES (4)· patent assignee history
2013–2020Based in Saffron Walden, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DARWIN DISCOVERY LTD | 8 | 2000–2004 |
| SHARPE ANDREWself | 6 | 2012–2014 |
| UCB PHARMA SA | 6 | 2012–2014 |
| HAUGHAN ALAN FINDLAY | 5 | 2012–2014 |
| ALLEN DANIEL REES | 4 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Saffron Walden, GB | 13 | 2013–2020 |
| Cambridge, GB | 8 | 2000–2004 |
| Comfort, WV, US | 4 | 1987–1991 |
| Slough, GB | 1 | 2012 |
| Concord, NH, US | 1 | 1998 |